These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 26721593)
21. Peroxiredoxin III and sulfiredoxin together protect mice from pyrazole-induced oxidative liver injury. Bae SH; Sung SH; Lee HE; Kang HT; Lee SK; Oh SY; Woo HA; Kil IS; Rhee SG Antioxid Redox Signal; 2012 Nov; 17(10):1351-61. PubMed ID: 22490042 [TBL] [Abstract][Full Text] [Related]
22. A novel synthetic analog of Militarin, MA-1 induces mitochondrial dependent apoptosis by ROS generation in human lung cancer cells. Yoon DH; Lim MH; Lee YR; Sung GH; Lee TH; Jeon BH; Cho JY; Song WO; Park H; Choi S; Kim TW Toxicol Appl Pharmacol; 2013 Dec; 273(3):659-71. PubMed ID: 24161344 [TBL] [Abstract][Full Text] [Related]
23. Sulfiredoxin-1 protects against simulated ischaemia/reperfusion injury in cardiomyocyte by inhibiting PI3K/AKT-regulated mitochondrial apoptotic pathways. Zhang J; He Z; Guo J; Li Z; Wang X; Yang C; Cui X Biosci Rep; 2016; 36(2):. PubMed ID: 26992405 [TBL] [Abstract][Full Text] [Related]
24. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells. Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518 [TBL] [Abstract][Full Text] [Related]
25. Nrf2-activated expression of sulfiredoxin contributes to urethane-induced lung tumorigenesis. Mishra M; Jiang H; Chawsheen HA; Gerard M; Toledano MB; Wei Q Cancer Lett; 2018 Sep; 432():216-226. PubMed ID: 29906488 [TBL] [Abstract][Full Text] [Related]
26. Induction of sulfiredoxin via an Nrf2-dependent pathway and hyperoxidation of peroxiredoxin III in the lungs of mice exposed to hyperoxia. Bae SH; Woo HA; Sung SH; Lee HE; Lee SK; Kil IS; Rhee SG Antioxid Redox Signal; 2009 May; 11(5):937-48. PubMed ID: 19086807 [TBL] [Abstract][Full Text] [Related]
27. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer. Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204 [TBL] [Abstract][Full Text] [Related]
28. Juglanin induces apoptosis and autophagy in human breast cancer progression via ROS/JNK promotion. Sun ZL; Dong JL; Wu J Biomed Pharmacother; 2017 Jan; 85():303-312. PubMed ID: 27899257 [TBL] [Abstract][Full Text] [Related]
29. Periovulatory expression of hydrogen peroxide-induced sulfiredoxin and peroxiredoxin 2 in the rat ovary: gonadotropin regulation and potential modification. Park JI; Jeon HJ; Jung NK; Jang YJ; Kim JS; Seo YW; Jeong M; Chae HZ; Chun SY Endocrinology; 2012 Nov; 153(11):5512-21. PubMed ID: 22989627 [TBL] [Abstract][Full Text] [Related]
30. Breaking down Leukemia Walls: Heteronemin, a Sesterterpene Derivative, Induces Apoptosis in Leukemia Molt4 Cells through Oxidative Stress, Mitochondrial Dysfunction and Induction of Talin Expression. Chen YC; Lu MC; El-Shazly M; Lai KH; Wu TY; Hsu YM; Lee YL; Liu YC Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29914195 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of cancer growth in vitro and in vivo by a novel ROS-modulating agent with ability to eliminate stem-like cancer cells. Wang J; Luo B; Li X; Lu W; Yang J; Hu Y; Huang P; Wen S Cell Death Dis; 2017 Jun; 8(6):e2887. PubMed ID: 28640251 [TBL] [Abstract][Full Text] [Related]
32. A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway. Tian HL; Yu T; Xu NN; Feng C; Zhou LY; Luo HW; Chang DC; Le XF; Luo KQ Cancer Lett; 2010 Nov; 297(1):18-30. PubMed ID: 20494511 [TBL] [Abstract][Full Text] [Related]
33. Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells. Chen X; Zhao Y; Luo W; Chen S; Lin F; Zhang X; Fan S; Shen X; Wang Y; Liang G Theranostics; 2020; 10(22):10290-10308. PubMed ID: 32929349 [No Abstract] [Full Text] [Related]
34. Investigation of the mechanism and apoptotic pathway induced by 4β cinnamido linked podophyllotoxins against human lung cancer cells A549. Kamal A; Nayak VL; Bagul C; Vishnuvardhan MV; Mallareddy A Apoptosis; 2015 Nov; 20(11):1518-29. PubMed ID: 26386574 [TBL] [Abstract][Full Text] [Related]
35. The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance. Manna A; De Sarkar S; De S; Bauri AK; Chattopadhyay S; Chatterjee M Phytomedicine; 2015 Jul; 22(7-8):713-23. PubMed ID: 26141757 [TBL] [Abstract][Full Text] [Related]
36. The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma. Stewart JH; Tran TL; Levi N; Tsai WS; Schrump DS; Nguyen DM J Surg Res; 2007 Jul; 141(1):120-31. PubMed ID: 17574045 [TBL] [Abstract][Full Text] [Related]
37. Antibiotic drug levofloxacin inhibits proliferation and induces apoptosis of lung cancer cells through inducing mitochondrial dysfunction and oxidative damage. Song M; Wu H; Wu S; Ge T; Wang G; Zhou Y; Sheng S; Jiang J Biomed Pharmacother; 2016 Dec; 84():1137-1143. PubMed ID: 27780143 [TBL] [Abstract][Full Text] [Related]
38. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity. Zheng CY; Lam SK; Li YY; Ho JC Int J Oncol; 2015 Mar; 46(3):1067-78. PubMed ID: 25572414 [TBL] [Abstract][Full Text] [Related]
39. Calf Spleen Extractive Injection (CSEI), a small peptides enriched extraction, induces human hepatocellular carcinoma cell apoptosis via ROS/MAPKs dependent mitochondrial pathway. Jia D; Lu W; Zhang X; Cai G; Teng L; Wang X; Zhang M; Zeng Y; Liang C; Wang D J Pharmacol Sci; 2016 Oct; 132(2):122-130. PubMed ID: 28314430 [TBL] [Abstract][Full Text] [Related]
40. Deoxypodophyllotoxin triggers parthanatos in glioma cells via induction of excessive ROS. Ma D; Lu B; Feng C; Wang C; Wang Y; Luo T; Feng J; Jia H; Chi G; Luo Y; Ge P Cancer Lett; 2016 Feb; 371(2):194-204. PubMed ID: 26683770 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]